Arzeda and KENT Specialty Milling Partner on AI Protein Design Collaboration
Arzeda and KENT Specialty Milling have entered a product development collaboration to create new proteins using AI-based design technology, announced in a press release.
The partnership will combine Arzeda's Intelligent Protein Design Technology with KENT's application and market expertise to explore new methods that improve performance and efficiency across target markets. The collaboration is intended to design and validate novel proteins with specific performance characteristics.
Arzeda's platform uses AI-based design, lab testing, and process development to create and manufacture proteins tailored for particular applications. KENT Specialty Milling contributes manufacturing and market knowledge to help move these innovations toward scalable production. Specific technical milestones have not been disclosed.
We hope you enjoyed this article
Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.
Also, consider following us on social media:
More from Life Sciences
Oct 16 Study Tests Smartphone AI for Children's Lung Sounds Oct 16 Manhattan Physician Invests in RunPractice Oct 16 Attilio appoints Buck Institute CEO Eric Verdin as cochairman Oct 16 Aignostics launches HETA Clinical for pathology workflows Oct 16 Specialty1 Partners Invests in AI for Dental Practice OperationsLife AI Weekly
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
Market report
2025 Generative AI in Professional Services Report
Thomson Reuters
This report by Thomson Reuters explores the integration and impact of generative AI technologies, such as ChatGPT and Microsoft Copilot, within the professional services sector. It highlights the growing adoption of GenAI tools across industries like legal, tax, accounting, and government, and discusses the challenges and opportunities these technologies present. The report also examines professionals' perceptions of GenAI and the need for strategic integration to maximize its value.
Read moreYou may also like
Arcadis Expands Autodesk Collaboration for AI Project Delivery
OrbitronAI and Aramco Digital Partner on Industrial AI Agents
Danaher Plans AI Autonomous Lab for Antibody Research
Hansa Biopharma Partners With Cradle on AI Protein Design
Zealand Pharma signs AI obesity drug deal worth up to $1.2 billion
Daily AI Brief: the AI news that matters, in your inbox.